Myriad Genetics (MYGN) Cash from Investing Activities Growth (1y) (2010 - 2026)
Myriad Genetics (MYGN) Cash from Investing Activities Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | 465.38% |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | -1,600.38% |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | -2.89% |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | -13.29% |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | 32.46% |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | 35.74% |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | -91.12% |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | -480.95% |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | -353.86% |
| 10 | Myriad Genetics | 414.15 Mn | 289.75 Mn | 137.60 Mn | 21.69% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.69% |
| Dec 31, 2025 | -1.69% |
| Sep 30, 2025 | -182.67% |
| Jun 30, 2025 | -7.81% |
| Mar 31, 2025 | -16.90% |
| Dec 31, 2024 | 50.83% |
| Sep 30, 2024 | 400.00% |
| Jun 30, 2024 | -154.24% |
| Mar 31, 2024 | -120.52% |
| Dec 31, 2023 | 66.29% |
| Sep 30, 2023 | -121.93% |
| Jun 30, 2023 | 198.33% |
| Mar 31, 2023 | 183.78% |
| Dec 31, 2022 | -37.45% |
| Sep 30, 2022 | -96.08% |
| Jun 30, 2022 | -1,190.91% |
| Mar 31, 2022 | -603.66% |
| Dec 31, 2021 | -192.50% |
| Sep 30, 2021 | 1,601.75% |
| Jun 30, 2021 | -96.73% |